Hologic Financial Statements (HOLX)
|
|
|
|
Report date
|
|
|
16.11.2021 |
15.11.2022 |
21.11.2023 |
27.11.2024 |
18.11.2025 |
|
29.01.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
5 632 |
4 863 |
4 030 |
4 030 |
4 101 |
|
4 126 |
|
Operating Income, bln rub |
|
|
2 480 |
1 640 |
668.4 |
882.6 |
714.3 |
|
721.6 |
|
EBITDA, bln rub |
? |
|
2 862 |
2 113 |
1 111 |
1 296 |
1 024 |
|
1 014 |
|
Net profit, bln rub |
? |
|
1 872 |
1 302 |
456.0 |
789.5 |
565.7 |
|
543.9 |
|
|
OCF, bln rub |
? |
|
2 330 |
2 126 |
1 051 |
1 285 |
1 057 |
|
1 098 |
|
CAPEX, bln rub |
? |
|
177.7 |
127.2 |
150.2 |
140.2 |
137.0 |
|
98.1 |
|
FCF, bln rub |
? |
|
2 153 |
1 999 |
901.0 |
1 145 |
920.1 |
|
999.6 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
|
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
1 316 |
1 357 |
1 403 |
1 345 |
1 787 |
|
1 458 |
|
Cost of production, bln rub |
|
|
1 837 |
1 865 |
1 959 |
1 803 |
1 599 |
|
1 947 |
|
R&D, bln rub |
|
|
276.3 |
283.4 |
294.3 |
272.8 |
248.2 |
|
248.5 |
|
Interest expenses, bln rub |
|
|
93.6 |
95.1 |
111.1 |
122.1 |
42.7 |
|
95.2 |
|
|
Assets, bln rub |
|
|
8 920 |
9 071 |
9 139 |
9 156 |
9 015 |
|
9 181 |
|
Net Assets, bln rub |
? |
|
4 219 |
4 876 |
5 017 |
5 130 |
5 048 |
|
5 245 |
|
Debt, bln rub |
|
|
3 145 |
2 922 |
2 904 |
2 658 |
2 627 |
|
2 520 |
|
Cash, bln rub |
|
|
1 170 |
2 340 |
2 723 |
2 334 |
2 203 |
|
2 365 |
|
Net debt, bln rub |
|
|
1 974 |
582.1 |
181.6 |
324.4 |
424.1 |
|
155.6 |
|
|
Ordinary share price, rub |
|
|
73.8 |
64.5 |
69.4 |
81.5 |
|
|
76.0 |
|
Number of ordinary shares, mln |
|
|
257.0 |
251.5 |
246.8 |
235.7 |
227.2 |
|
224.4 |
|
|
Market cap, bln rub |
|
|
18 973 |
16 229 |
17 126 |
19 202 |
0 |
|
17 057 |
|
EV, bln rub |
? |
|
20 947 |
16 811 |
17 308 |
19 526 |
424 |
|
17 213 |
|
Book value, bln rub |
|
|
-722 |
359 |
847 |
842 |
818 |
|
1 053 |
|
|
EPS, rub |
? |
|
7.28 |
5.18 |
1.85 |
3.35 |
2.49 |
|
2.42 |
|
FCF/share, rub |
|
|
8.37 |
7.95 |
3.65 |
4.86 |
4.05 |
|
4.45 |
|
BV/share, rub |
|
|
-2.81 |
1.43 |
3.43 |
3.57 |
3.60 |
|
4.69 |
|
|
EBITDA margin, % |
? |
|
50.8% |
43.5% |
27.6% |
32.2% |
25.0% |
|
24.6% |
|
Net margin, % |
? |
|
33.2% |
26.8% |
11.3% |
19.6% |
13.8% |
|
13.2% |
|
FCF yield, % |
? |
|
11.3% |
12.3% |
5.26% |
5.96% |
|
|
5.86% |
|
ROE, % |
? |
|
44.4% |
26.7% |
9.09% |
15.4% |
11.2% |
|
10.4% |
|
ROA, % |
? |
|
21.0% |
14.4% |
4.99% |
8.62% |
6.28% |
|
5.92% |
|
|
P/E |
? |
|
10.1 |
12.5 |
37.6 |
24.3 |
0.00 |
|
31.4 |
|
P/FCF |
|
|
8.81 |
8.12 |
19.0 |
16.8 |
0.00 |
|
17.1 |
|
P/S |
? |
|
3.37 |
3.34 |
4.25 |
4.76 |
0.00 |
|
4.13 |
|
P/BV |
? |
|
-26.3 |
45.2 |
20.2 |
22.8 |
0.00 |
|
16.2 |
|
EV/EBITDA |
? |
|
7.32 |
7.95 |
15.6 |
15.1 |
0.41 |
|
17.0 |
|
Debt/EBITDA |
|
|
0.69 |
0.28 |
0.16 |
0.25 |
0.41 |
|
0.15 |
|
|
R&D/CAPEX, % |
|
|
155.5% |
222.8% |
195.9% |
194.6% |
181.2% |
|
253.3% |
|
|
CAPEX/Revenue, % |
|
|
3.16% |
2.62% |
3.73% |
3.48% |
3.34% |
|
2.38% |
|
| Hologic shareholders |
